Arrowstreet Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$246M Sell
1,004,689
-1,504,237
-60% -$350M 0.13% 147
2025
Q4
$519M Buy
2,508,926
+194,456
+8% +$38.5M 0.3% 73
2025
Q3
$429M Sell
2,314,470
-144,688
-6% -$24.8M 0.27% 76
2025
Q2
$376M Sell
2,459,158
-842,198
-26% -$129M 0.27% 80
2025
Q1
$547M Buy
3,301,356
+934,696
+39% +$146M 0.44% 42
2024
Q4
$342M Buy
2,366,660
+1,213,804
+105% +$188M 0.27% 72
2024
Q3
$187M Buy
1,152,856
+324,740
+39% +$51.7M 0.16% 120
2024
Q2
$121M Buy
828,116
+121,456
+17% +$18.1M 0.11% 164
2024
Q1
$112M Buy
+706,660
New +$112M 0.1% 179
2023
Q4
Sell
-41,553
Closed -$6.47M 1485
2023
Q3
$6.47M Buy
+41,553
New +$6.86M 0.01% 618
2023
Q2
Sell
-1,214,563
Closed -$188M 1359
2023
Q1
$188M Buy
1,214,563
+418,859
+53% +$67.6M 0.24% 107
2022
Q4
$141M Buy
795,704
+702,949
+758% +$121M 0.2% 130
2022
Q3
$15.2M Buy
92,755
+62,901
+211% +$10.6M 0.02% 425
2022
Q2
$5.3M Sell
29,854
-6,623,756
-100% -$1.18B 0.01% 598
2022
Q1
$1.18B Buy
6,653,610
+1,805,632
+37% +$307M 1.47% 6
2021
Q4
$829M Sell
4,847,978
-456,414
-9% -$74.7M 1.01% 11
2021
Q3
$857M Sell
5,304,392
-1,624,375
-23% -$277M 1.07% 13
2021
Q2
$1.14B Sell
6,928,767
-2,076,227
-23% -$344M 1.4% 8
2021
Q1
$1.48B Buy
9,004,994
+2,688,957
+43% +$435M 1.98% 3
2020
Q4
$994M Sell
6,316,037
-1,418,237
-18% -$209M 1.4% 8
2020
Q3
$1.15B Sell
7,734,274
-152,506
-2% -$22.6M 1.82% 5
2020
Q2
$1.11B Buy
7,886,780
+819,350
+12% +$119M 2.04% 3
2020
Q1
$927M Buy
7,067,430
+4,551,801
+181% +$646M 2.61% 4
2019
Q4
$367M Sell
2,515,629
-238,661
-9% -$32.4M 0.85% 18
2019
Q3
$356M Buy
2,754,290
+394,185
+17% +$51.9M 0.83% 18
2019
Q2
$329M Buy
2,360,105
+145,426
+7% +$20.1M 0.73% 31
2019
Q1
$310M Buy
2,214,679
+1,177,416
+114% +$158M 0.73% 27
2018
Q4
$134M Buy
1,037,263
+1,011,263
+3,889% +$141M 0.35% 69
2018
Q3
$3.59M Sell
26,000
-2,705,113
-99% -$359M 0.01% 575
2018
Q2
$331M Sell
2,731,113
-395,006
-13% -$49.3M 0.81% 24
2018
Q1
$401M Buy
3,126,119
+2,267,727
+264% +$307M 0.92% 23
2017
Q4
$120M Buy
858,392
+14,039
+2% +$1.96M 0.29% 91
2017
Q3
$110M Buy
844,353
+630,653
+295% +$83.6M 0.29% 84
2017
Q2
$28.3M Buy
213,700
+196,700
+1,157% +$25.1M 0.09% 211
2017
Q1
$2.12M Buy
+17,000
New +$2.03M 0.01% 806
2016
Q4
Sell
-19,700
Closed -$2.33M 2096
2016
Q3
$2.33M Sell
19,700
-224,697
-92% -$27.3M 0.01% 876
2016
Q2
$29.6M Buy
244,397
+105,197
+76% +$12M 0.1% 209
2016
Q1
$15.1M Buy
+139,200
New +$14.4M 0.06% 287
2015
Q4
Sell
-240,913
Closed -$22.5M 1495
2015
Q3
$22.5M Sell
240,913
-1,073,887
-82% -$104M 0.11% 196
2015
Q2
$128M Buy
1,314,800
+1,270,300
+2,855% +$127M 0.72% 27
2015
Q1
$4.48M Buy
+44,500
New +$4.53M 0.03% 436
2014
Q4
Sell
-2,106,940
Closed -$225M 1283
2014
Q3
$225M Sell
2,106,940
-1,010,544
-32% -$105M 1.21% 14
2014
Q2
$326M Buy
+3,117,484
New +$315M 1.68% 5
2014
Q1
Sell
-34,366
Closed -$3.15M 1231
2013
Q4
$3.15M Sell
34,366
-614,857
-95% -$56.7M 0.02% 556
2013
Q3
$56.3M Buy
649,223
+293,721
+83% +$26.4M 0.36% 73
2013
Q2
$30.5M Buy
+355,502
New +$30.2M 0.23% 106

Other funds holding JNJ

Arrowstreet Capital's JNJ Position: Q1 2026 in Review

Arrowstreet Capital reduced its Johnson & Johnson (JNJ) stake by 60% in Q1 2026, selling an estimated $350M and leaving 1,004,689 shares worth $246M. The position accounts for 0.13% of the portfolio, ranked #147.

Arrowstreet Capital first reported a position in JNJ in Q2 2013 and has held it in 46 quarters since. The position peaked at $1.48B in Q1 2021. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Arrowstreet Capital held 1,004,689 shares of Johnson & Johnson worth $246M as of Q1 2026.
  • Arrowstreet Capital sold 1,504,237 Johnson & Johnson shares in Q1 2026, an estimated $350M.
  • Johnson & Johnson made up 0.13% of Arrowstreet Capital's portfolio in Q1 2026, its #147 holding.
  • Arrowstreet Capital first reported a position in Johnson & Johnson in Q2 2013 and has held it in 46 quarters since.
  • Arrowstreet Capital's Johnson & Johnson position peaked at $1.48B in Q1 2021.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.